Skip to main content
Equibles

TAK · Takeda Pharmaceutical Co Ltd · Webcasts, Transcripts & Audio

Track TAK — free

Use TAK with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TAK.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$21.43 +0.31 (+1.47%) At close · Nov 13 Play latest call Q1 2027 earnings call transcript
Rebalance outlook locked
Market Cap
$68.47B
Shares
3.19B
Volume · Nov 13 3.75M Avg daily vol (3M) 2.65M

Takeda Pharmaceutical Co Ltd Webcasts

Earnings calls, investor updates, investor days and conferences for Takeda Pharmaceutical Co Ltd (TAK), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP → Add these events to your calendar (.ics)

Embed Takeda Pharmaceutical Co Ltd earnings calls on your site

Pick a widget, match your page, then paste the code where it should appear.

Widget
Theme
Accent color Pro

Match your site's colors with Pro. The Equibles credit stays on every plan.

Embed code 

                    
The widget credits Equibles and keeps the link below it on every plan.

                

            


            

                Preview
                
            

        

        
    

    




    
    
    


        

    

        

            

                Key facts
                    
                        CIK
                        1395064
                    
                    
                        CUSIP
                        874060205
                    
                    
                        13F (30d)
                        359 filings
                        305 filers
                    
                    
                    
                         Visit website
                        
                    
                    
                         Investor relations